| |
LLP exposures |
TLL exposures |
| Ocular route |
|
|
| alone |
n=57 |
n=12 |
| 57 keratitis (one requiring amniotic membrane transplantation) |
12 keratitis |
| associated with other exposure routes |
n=26 |
n=1 |
| 26 keratitis (one associated with cutaneous necrosis) |
keratitis and skin burns (due to prolonged contact and coma related to co-ingestion of meprobamate) |
| Ingestion |
|
|
| alone |
n=21 (managed in an intensive care unit =6; death=0) |
n= 13 (managed in an intensive care unit=5; deaths =2) |
| - 8 pneumonias |
- 9 pneumonias |
| - 9 respiratory distresses: |
- 1 respiratory distress with laryngeal origin |
| - 1 bronchospasm |
- 1 bronchospasm |
| - 2 laryngeal spasm |
- 1 bronchial congestion without respiratory distress |
| - 5 major bronchial congestion |
- 1 lesionaledema |
| - 1 unspecified |
|
| - 2 bronchial congestion, without respiratory distress |
|
| - 2 laryngeal edema |
|
| Total |
n=104 |
n= 26 |
